Skip to content

Steven M. Southwick

8 papers in the library · 1,147 citations · publishing 1998-2022

Papers

Sort Most recent Most cited

Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial.

Neuropsychopharmacology July 2022 Chadi G. Abdallah, John D Roache, Ralitza Gueorguieva et al.

This study tested the efficacy of repeated intravenous ketamine doses to reduce symptoms of posttraumatic stress disorder (PTSD). Veterans and service members with PTSD (n = 158) who failed previous antidepressant treatment were randomized to 8 infusions administered twice weekly of intravenous placebo (n = 54), low dose (0.2 mg/kg; n = 53) or standard dose (0.5 mg/kg; n = 51) ketamine....

mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression.

Journal of Affective Disorders 2022 Lynnette A. Averill, Christopher L. Averill, Ralitza Gueorguieva et al.

Suicide is a public health crisis with limited treatment options. Ketamine has demonstrated rapid and robust improvements in suicidal ideation (SI). The parent study for the secondary pilot analyses presented here was a double-blind, cross-over trial that found pretreatment with the mechanistic target of rapamycin complex 1 (mTORC1) prolonged the antidepressant effects of ketamine. Here we...

Mindfulness as a mediator between trauma exposure and mental health outcomes: Results from the National Health and Resilience in Veterans Study.

Psychological Trauma: Theory, Research, Practice and Policy January 21, 2021 Lorig K Kachadourian, Ilan Harpaz-Rotem, Jack Tsai et al.

Objective: Exposure to traumatic life events is associated with increased risk of posttraumatic stress disorder (PTSD) and other mental health problems such as suicidal ideation (SI), alcohol use disorder (AUD), and decreased quality of life (QOL). Mindfulness, which involves attending to the present moment, may help individuals cope with traumatic events by increasing acceptance of...

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

Neuropsychopharmacology February 24, 2020 Chadi G. Abdallah, Lynnette A. Averill, Ralitza Gueorguieva et al. 181 citations

Twenty-four hours after administration, ketamine exerts rapid and robust antidepressant effects that are thought to be mediated by activation of the mechanistic target of rapamycin complex 1 (mTORC1). To test this hypothesis, depressed patients were pretreated with rapamycin, an mTORC1 inhibitor, prior to receiving ketamine. Twenty patients suffering a major depressive episode were randomized...

A Multisite Randomized Controlled Trial of Mindfulness-Based Stress Reduction in the Treatment of Posttraumatic Stress Disorder.

Psychiatric Research and Clinical Practice October 1, 2019 Lori L. Davis, Charles Whetsell, Mark B Hamner et al.

Posttraumatic stress disorder (PTSD) is often difficult to treat, and many patients do not achieve full remission. Complementary and integrative health approaches, such as mindfulness meditation, are intended to be integrated with evidence-based treatment. This study examined the efficacy of mindfulness-based stress reduction (MBSR) in the treatment of PTSD in U.S. military veterans. Veterans...

Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic

Current Psychiatry Reports August 26, 2017 J. Krystal, Chadi G. Abdallah, Lynnette A. Averill et al.

Purpose of ReviewStudies of the neurobiology and treatment of PTSD have highlighted many aspects of the pathophysiology of this disorder that might be relevant to treatment. The purpose of this review is to highlight the potential clinical importance of an often-neglected consequence of stress models in animals that may be relevant to PTSD: the stress-related loss of synaptic...

Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation.

October 1, 1999 R. Andrew Chambers, J. Douglas Bremner, Bita Moghaddam et al. 140 citations

Dissociative cognitive and perceptual alterations commonly occur at the time of traumatization and as an enduring feature of post-traumatic stress disorder (PTSD). After stress exposure, dissociative symptoms are a predictor of the development of PTSD. Recent preclinical data suggest that stress stimulates the cortico-limbic release of glutamate. The glutamate that is released during stress in...

DOI: 10.153/scnp00400274 (opens in new tab) Ketamine Nmda receptor Glutamate receptor Dissociative +3

Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)

Journal of Traumatic Stress 1998 J. Douglas Bremner, John H. Krystal, Frank W. Putnam et al. 826 citations

The purpose of this study was to develop an instrument for the measurement of present-state dissociative symptoms, the Clinician Administered Dissociative States Scale (CADSS). Reported here are interrater reliability and internal consistency of the CADSS, validity as assessed by comparisons with other instruments for the assessment of dissociation, and sensitivity of the CADSS to discriminate...

DOI: 10.1023/a:1024465317902 (opens in new tab) Dissociative disorders Inter-rater reliability Dissociation chemistry Construct validity +8